SCHEMBL13579148

SCHEMBL13579148

C#CC(=O)N(c1cccc(C(F)(F)F)c1)C(C(=O)NC1CCCCC1)c1cccc(N)c1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ EPHX2 P34913 1/20 0.43
▸ GAA P10253 3/20 0.41
▸ LMNA P02545 3/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ KMT2A Q03164 6/20 0.40
▸ MEN1 O00255 5/20 0.40
▸ L3MBTL1 Q9Y468 2/20 0.40
▸ POLB P06746 2/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ MAPT P10636 3/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ HTR1E P28566 1/20 0.39
▸ S1PR3 Q99500 1/20 0.39
▸ TSHR P16473 1/20 0.38
▸ PTGS1 P23219 1/20 0.38
▸ HTT P42858 2/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38
▸ ALOX12 P18054 1/20 0.38
▸ EPHX1 P07099 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12639506 0.91 LMNA (0.47) EPHX2GAALMNASMN1; SMN2KMT2A
SCHEMBL12639503 0.90 KMT2A (0.45) EPHX2KMT2AMEN1KDM4EALDH1A1
SCHEMBL12639550 0.89 GAA (0.44) EPHX2GAALMNASMN1; SMN2KMT2A
SCHEMBL12672265 0.89 EPHX2 (0.43) EPHX2GAALMNASMN1; SMN2KMT2A
SCHEMBL12639581 0.89 KMT2A (0.45) EPHX2GAALMNASMN1; SMN2KMT2A
SCHEMBL12639608 0.89 EPHX2 (0.46) EPHX2GAALMNASMN1; SMN2KMT2A
SCHEMBL12639601 0.88 EPHX2 (0.42) EPHX2GAALMNASMN1; SMN2KMT2A
SCHEMBL12639586 0.88 EPHX2 (0.42) EPHX2GAALMNASMN1; SMN2KMT2A
SCHEMBL15189094 0.88 GAA (0.52) EPHX2GAALMNASMN1; SMN2KMT2A
SCHEMBL12639594 0.88 LMNA (0.45) EPHX2GAALMNASMN1; SMN2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009150248-A1 COMPOUNDS WHICH CAN BE USED FOR THE TREATMENT OF CANCERS CYTOMICS SYSTEMS (FR) 2009-12-17 — — WO disclosed
Send feedback